Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
29-Sep-17 According to the Registrar General of India, coronary heart disease is currently the cause of 32% of total adult deaths and cardiovascular diseases will be the largest cause of death and disability in India by 2020. [image: ET Healthworld]
Read More
28-Sep-17 In Jun-17 Myanmar relaxed prohibitions on foreign trading, allowing 100% foreign-owned companies to sell certain hospital equipment. Myanmar needs to be less reliant on offshore manufacturing. With the increase in private medical insurance, opportunities abound for investors. [image: The Myanmar Times]
Read More
28-Sep-17 According to the Korean government's biotechnology development plan, the government will increase the number of new drug candidates by 100 to 185 in 2026 and help companies come up with at least five new blockbuster drugs. [image: Business Korea]
Read More
20-Sep-17 MedAnt, a ground-breaking new patient information sharing app has launched on the WeChat platform in China, focusing mainly on oncology and ophthalmology. MedAnt is a social app where patients share experiences via paid Q&A and free group chats. [image: Weixin]
Read More
27-Sep-17 Livanova and MicroPort Scientific have announced that the companies’ Shanghai-based joint venture MicroPort Sorin Cardiac Rhythm Management obtained approval for its family of Rega pacemakers, from the China Food & Drug Administration. [image: Shine]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com